Hyperion Therapeutics Shareholder Alert - National Securities Law Firm Seeks Higher Price for Shareholders in Connection with Acquisition. Encourages Shareholders to Contact Law Firm for More Information
NEW YORK, March 30, 2015 /PRNewswire/ -- Tripp Levy PLLC, a leading national securities and shareholder rights law firm, announces that it is investigating the acquisition of Hyperion Therapeutics, Inc. (NASDAQ: "HPTX") ("Hyperion" or the "Company") on behalf of its shareholders. Horizon Pharma plc will acquire all of the outstanding shares of Hyperion's common stock for $46 per share.
Our investigation has determined that the offer price of only $46 per share unfairly under-values the true going forward inherent value of Hyperion and that shareholders are not receiving the maximum value for their shares. Indeed, among other things, analysts have projected that Hyperion's stock is worth at least $52 per share, and the buyout of Hyperion will be immediately accretive to Horizon Pharma's adjusted EPS, and will add approximately $100 million to its adjusted EBITDA in 2016. The investigation further seeks to determine whether senior management of Hyperion are acting in their own self-interests at the expense of shareholders. Certain members of Hyperion management team and certain funds affiliated with members of the Hyperion board of directors have agreed to tender their shares in favor of the merger.
If you are a shareholder of Hyperion and would like additional information as to how the acquisition may affect your rights as a shareholder, and how you may be eligible to obtain a higher price for your shares, please call us at no cost at:
Tripp Levy PLLC
New York, New York
Toll free: 800-511-7037
International: 602-241-2841
Email: [email protected]
www.tripplevy.com/participate-in-an-action
Tripp Levy PLLC represents individual and institutional shareholders in mergers and acquisitions transactions and, along with its affiliate, has recovered billions of dollars for shareholders in securities actions around the globe. Tripp Levy PLLC is affiliated with the law firm Milberg LLP. The National Law Journal has named Milberg one of the "50 Elite Trial Lawyer Firms" and one of the "50 Leading Plaintiff Firms in America." Attorney advertising. Prior results do not indicate a similar outcome.
SOURCE Tripp Levy PLLC
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article